Minnesota RETAIN Phase 3
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
MN RETAIN Phase 3 is a non-randomized trial to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. The program is funded by US Department of Education (DOE). There will be collaboration between partners to implement best practices in early intervention to support injured or ill employees in stay-at-work and return-to-work. MN RETAIN involves a partnership between Mayo Clinic and MN Department of Employment and Economic Development (DEED), and stakeholders throughout MN. MN DEED serves as the main recipient and administrator of the funding within the state with Mayo Clinic a subrecipients of the grant.
Eligibility criteria
Qualifiers
> 18-years-old,
MN Resident,
Works or intends to work in MN,
Employed at the time of enrollment (must be a W2 employee) OR,
Disqualifiers
Does not have the capacity to give appropriate informed consent,
Active workers' compensation claim relating to the qualifying injury or illness,
Pending application OR Receiving Social Security Disability Insurance (SSDI) or -Supplemental Security Income (SSI),
Self-Employed (i.e., 1099 worker)
Trial design
Treatments tested in this trial
- RETAIN Program
Treatment groups
1,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Mayo Clinic
Lead sponsor
Minnesota Department of Employment and Economic Development
Collaborator
U.S. Department of Education
Collaborator
Source ClinicalTrials.gov